1Pengo V, Lensing AWA, Prins MH, et al. Incidence of chronic thromboemholic pulmonary hypertension hypertension without major vessel obstruction.Chest, 2003,123,1583-1588.After pulmonary embolismm. N Engl J Med, 2004,350(22):2257-2264.
2Williamson TL, Kin NH, Rubin LJ, et al. Chronicthromboembolic pulmonary hypertension. Pro cardiol Dis, 2002,45(3)203-212.
3Arbustini E, Morbini P, Armini AMD, et al. Plaque compostini in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart, 2002, 88(2):177-182.
5Bergin CJ, Hauschildt JP, Brown MA, et al. Identifying the cause of unilateral hyplperfusion in patients suspected to have chronic pulmonary thromboembolism: diagnostic accuracey of helical CT and conventional angiography. Radiology, 1999,213:743-749.
7Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with cronic pulmonary embolism. Chest, 2001,119;818-823.
8Bresser P, Fedullo PF, Auger WR, et al. Contnuous in travenous epoprostenol for chronic throumboembolic pulmonary hypertension. Eur Respir J, 2004,23(4):595-600.
9Kramm T, Eberle B, Krummenauer F, et al. Inhalediloprost in patients with chronic throboembolic pulmonary hypertension: effects before and after pulnomnary thromboendarterectomy. Ann Thorac Surg, 2003,76:711-718.
10Ono F, Noritoshi, N, Okumura, H, et al Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction.Chest.2003,123.1583-1588.
